Cursons Joseph J

Show results for

Models (1)
Unknown (1)
Proteomics (1)

Organisms

Homo sapiens (1)
Andropogon gerardi (1)
Bacteria (1)
Canis lupus familiaris (1)
Chromatiales bacterium OalgGamma1 (1)
Clavibacter nebraskensis NCPPB 2581 (1)
Cnidaria (1)
Ensifer adhaerens (1)
Fasciola (1)
Human alphaherpesvirus 1 strain 17 (1)
Human alphaherpesvirus 1 strain KOS (1)
Human betaherpesvirus 5 (1)
Human herpesvirus 2 strain 186 (1)
Mesocricetus auratus (1)
Miscanthus x giganteus (1)
Mus musculus (1)
Panicum virgatum (1)
Platyhelminthes (1)
Pseudomonas aeruginosa PA103 (1)
Rabies virus Nishigahara RCEH (1)
Rattus norvegicus (1)
Rattus rattus (1)
Rhodococcus jostii RHA1 (1)
Rhodopseudomonas palustris (1)
Sorghastrum nutans (1)
Spirochaeta sp. ELBA (1)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (1)
Streptococcus pneumoniae (1)
Streptomyces coelicolor A3(2) (1)
Tripsacum dactyloides (1)

Repository

BioModels (1)
pride (1)

Tissue

Blood (1)
Natural killer cell (1)

Disease

Disease free (1)
Mature T-cell and NK-cell lymphoma (1)

Technology Type

Bottom-up proteomics (1)
Data-independent acquisition (1)
Mass Spectrometry (1)

Publication Date

2024 (1)
2025 (1)

UNIPROT ID/AC

P0DP23 (1)
P04049 (1)
Q02750 (1)
P28482 (1)

CHEBI ID

CHEBI:39124 (1)

IsPrivate

False (1)

Modelling Approach

Ordinary differential equation model (1)

Release Date

2021 (1)

Lab affiliation

Chief Scientific Officer oNKo-innate Pty Ltd Laboratory Head, Huntington Laboratory Monash Biomedicine Discovery Institute Monash University Victoria Australia (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Cursons2015 - Regulation of ERK-MAPK signaling in human epidermis

Cursons2015 - Regulation of ERK-MAPK signaling in human epidermis Model comparing the abundance of phosphorylated MAPK signalling proteins and calcium signalling in the epidermis. This model is described in the article: Regulation of ERK-MAPK signaling in human epidermis. Cursons ...

2024-09-02 | BIOMD0000000659 | BioModels

UBE2F inhibits Natural Killer cell tumor immunity by activating the ARIH2-CRL5 complex to degrade interleukin 15 receptors

Interleukin-15 receptor (IL-15R) agonists induce anti-tumor immunity in pre-clinical models, however, dose-limiting toxicity has hampered their clinical development. An alternative is to target pathways downstream of the IL-15R to access different therapeutic profiles. We performed genome-wide CRISP...

ORGANISM(S): Homo sapiens (Human)

2025-07-11 | PXD063595 | Pride

Globetrotting strangles: the unbridled national and international transmission of <i>Streptococcus equi</i> between horses.

Not available

S-EPMC8190609 | biostudies-literature

Previous page
1 / 1
You're on page 1
Next page